You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

childhood extracranial germ cell tumor

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cutaneous Squamous Cell Carcinoma, Actinic Keratoses, Skin Cancer Trial in Boston, Saint Louis (Calcipotriol Only Product in

Not yet recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +4 more
  • Calcipotriol Only Product in Cutaneous Dose Form
  • +2 more
  • Boston, Massachusetts
  • +1 more
Apr 5, 2022

Multiple Myeloma Trial in Torino (Cyclophosphamide, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Torino, Italy
    Division of Hematology, Molinette Hospital
Apr 6, 2022

Lung Cancer Trial (Lazertinib 240 mg)

Approved for marketing
  • Lung Cancer
  • Lazertinib 240 mg
  • (no location specified)
Feb 15, 2022

B-cell Acute Lymphoblastic Leukemia Trial (Tisagenlecleucel)

Withdrawn
  • B-cell Acute Lymphoblastic Leukemia
  • Tisagenlecleucel
  • (no location specified)
Feb 3, 2022

T Cell Non-Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, Not Otherwise Specified, Angioimmunoblastic T-cell Lymphoma Trial in

Recruiting
  • T Cell Non-Hodgkin Lymphoma
  • +3 more
  • AUTO4
  • Barcelona, Spain
  • +4 more
Feb 1, 2022

CMV Infection or Reactivation After Allogenic HSCT Trial in Sanhe (CMV-TCR-T cells)

Recruiting
  • CMV Infection or Reactivation After Allogenic HSCT
  • CMV-TCR-T cells
  • Sanhe, Hebei, China
    Hebei Yanda Ludaopei Hospital
Jan 29, 2022

Leukemia Trial in Germany (Amsacrine, Clofarabine, Cyclophosphamide)

Active, not recruiting
  • Leukemia
  • Bielefeld, Germany
  • +13 more
May 16, 2022

Head Neck Cancer, Oropharynx Cancer, Oropharyngeal Squamous Cell Carcinoma Trial in United States (Intensity modulated

Recruiting
  • Head and Neck Cancer
  • +2 more
  • Intensity modulated radiotherapy (IMRT)/volumetric modulated arc therapy (VMAT) or Pencil beam proton therapy (PBPT)
  • Baltimore, Maryland
  • +5 more
Apr 26, 2022

Solid Tumor Trial in Jinan (IBI325 + sintilimab, IBI325)

Active, not recruiting
  • Solid Tumor
  • Jinan, Shandong, China
    Shandong Province Cancer Hospital
Oct 10, 2022

Advanced Solid Tumor Trial in Shijiazhuang (Camrelizumab/sintilimab+ Standard chemo, Camrelizumab/sintilimab+

Recruiting
  • Advanced Solid Tumor
  • Camrelizumab/sintilimab+ Standard chemotherapy
  • +2 more
  • Shijiazhuang, Hebei, China
    The Fourth Hospital of Hebei Medical University
Dec 8, 2021

CD20-positive B-cell Non-Hodgkin Lymphoma Trial in Beijing (Recombinant anti-CD20 mAb-MMAE coupling agent for injection

Recruiting
  • CD20-positive B-cell Non-Hodgkin Lymphoma
  • Recombinant anti-CD20 monoclonal antibody-MMAE coupling agent for injection (TRS005)
  • Beijing, Beijing, China
    Chinese Academy of Medical Sciences, Cancer Hospital
May 24, 2022

MDS, Graft Vs Host Disease, Graft-versus-host-disease Trial in Miami (Busulfan, Melphalan, Fludarabine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Miami, Florida
    Miami Cancer Institute
Jan 10, 2023

Muscular Dystrophies, Muscular Dystrophy, Duchenne, Muscular Disorders, Atrophic Trial in Little Rock, Sacramento, Atlanta

Recruiting
  • Muscular Dystrophies
  • +7 more
  • CAP-1002
  • Placebo
  • Little Rock, Arkansas
  • +9 more
Jan 9, 2023

Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

Not yet recruiting
  • Recurrent Chronic Lymphocytic Leukemia
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 10, 2023

Diffuse Large B-cell Lymphoma Trial in Worldwide (Epcoritamab, Investigator's Choice Chemotherapy)

Recruiting
  • Diffuse Large B-cell Lymphoma
  • Epcoritamab
  • Investigator's Choice Chemotherapy
  • Irvine, California
  • +254 more
Jan 9, 2023

Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Indianapolis (Fludarabine + Total Marrow

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Fludarabine + Total Marrow Irradiation
  • Indianapolis, Indiana
    Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
Jun 1, 2022

NSCLC Trial in Goyang-Si (CA and Nivolumab)

Recruiting
  • Non-small Cell Lung Cancer
  • CA and Nivolumab
  • Goyang-Si, Gyeonggi-do, Korea, Republic of
    National Cancer Center
Apr 4, 2022

Gastric and Colorectal Cancer Trial in Wuhan (pemigatinib)

Recruiting
  • Gastric and Colorectal Cancer
  • Wuhan, Hubei, China
    Cancer Center, Union Hospital, Tongji Medical College, Huazhong
Jan 9, 2022

Burkitt Lymphoma, CD20-Positive Neoplastic Cells Present, DLBCL Trial in Seattle (biological, procedure, drug, radiation, other)

Terminated
Has Results
  • Burkitt Lymphoma
  • +6 more
  • Anti-CD20 B9E9 scFv-Streptavidin Fusion Protein
  • +11 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 30, 2020

Sarcoma Trial in Helsinki (Imatinib)

Recruiting
  • Sarcoma
  • Helsinki, Finland
    Helsinki University Central Hospital
Sep 26, 2022

Rotavirus Infection Trial in Perm, Tyumen (The pentavalent rotavirus vaccine (live attenuated oral, freeze-dried), Placebo)

Completed
  • Rotavirus Infection
  • The pentavalent rotavirus vaccine (live attenuated oral, freeze-dried)
  • Placebo
  • Perm, Russian Federation
  • +1 more
Sep 2, 2021

Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden Trial in Beijing (Chidamide, Decitabine, Chidamide and

Unknown status
  • Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinese PLA General Hospital
Dec 3, 2020

Glioblastoma Trial in Münster (Gliolan, Radiodynamic therapy)

Recruiting
  • Glioblastoma
  • Münster, Germany
    University Hospital Münster, Klinik für Neurochirurgie
Nov 16, 2022

Radiation Pneumonitis Trial in Zhuhai (Babaodan Capsule)

Recruiting
  • Radiation Pneumonitis
  • Babaodan Capsule
  • Zhuhai, Guangdong, China
    The Fifth Affiliated Hospital of Sun Yat-sen University
Oct 8, 2023

Giant Cell Arteritis Trial in Canada, United States (Abatacept, Placebo)

Recruiting
  • Giant Cell Arteritis
  • Rochester, Minnesota
  • +5 more
Jul 11, 2022